Recent News

• 02.06.2026 - Canopy Growth Reports Third Quarter Fiscal 2026 Financial Results; Delivers double digit net revenue growth in Canada Cannabis contributing to a narrowing net loss; financial strength of $371M in cash and cash equivalents with a net cash position of $146M at December 31, 2025
• 01.23.2026 - Canopy Growth to Report Third Quarter Fiscal 2026 Financial Results on February 6, 2026
• 01.08.2026 - Canopy Growth Announces Strategic Recapitalization Transactions Significantly Strengthening Balance Sheet to Support Growth Strategy
• 12.15.2025 - Canopy Growth to Acquire MTL Cannabis; Transaction Expected to Create Canada’s Leading Medical Cannabis Business and Enhance Capacity to Serve Growing International Demand
• 12.04.2025 - Canopy Growth Launches Claybourne Gassers Liquid Diamonds All-In-One Vapes in Canada, Expanding Footprint in High-Growth Vape Segment
• 11.18.2025 - Canopy Growth Expands Spectrum Therapeutics Portfolio in Australia with New Softgels

Recent Filings

• 02.06.2026 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 02.06.2026 - 8-K Current report
• 02.06.2026 - EX-99.1 EX-99.1
• 02.06.2026 - S-3 Registration statement under Securities Act of 1933
• 01.15.2026 - 424B3 Prospectus [Rule 424(b)(3)]
• 01.15.2026 - EFFECT Notice of Effectiveness
• 01.09.2026 - S-3 Registration statement under Securities Act of 1933
• 01.08.2026 - EX-99.1 EX-99.1
• 01.08.2026 - 8-K Current report
• 01.02.2026 - 4 Statement of changes in beneficial ownership of securities